The Impact of SARS-CoV-2 Transmission Fear and the COVID-19 Pandemic on the Mental Health of Patients with Primary Immunodeficiency Disorders and Severe Asthma, and Other High-Risk Groups

Öz:

Objective: The effect of the COVID-19 pandemic on mental health in the long term is unclear. We evaluated severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)–related transmission fear and mental-health disorders in populations at high risk for COVID-19. Materials and Methods: Healthcare workers and patients with primary immunodeficiency disorders (PIDs), severe asthma, malignancy, cardiovascular disease, hypertension, and diabetes mellitus were included in the study. The hospital anxiety and depression scale (HADS) and Fear of Illness and Virus Evaluation (FIVE) scales were applied during face-to-face interviews.Results: There was a total of 560 participants, 80 per group; 306 (55%) were female. The FIVE and HADS-A scale scores of health care workers were significantly higher than the other groups (p = 0.001 and 0.006). The second-highest scores were in patients with PID. There was no significant difference between the groups in HADS-D scores (p = 0.07). There was a significant positive correlation between FIVE scale scores and anxiety (r = 0.828; p < 0.001) and depression (r = 0.660; p < 0.001). The FIVE scale had significant discriminatory power for anxiety (AUC = 0.870, 95% confidence interval [CI] = 0.836–0.904; p < 0.0001) and depression (area under the curve = 0.760, 95% CI = 0.717–0.803; p < 0.0001). Conclusion: During the COVID-19 pandemic, mental-health disorders may develop in patients with comorbidities, especially healthcare workers. They should be referred to mental-health centers.

Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık

1. Kılınçel Ş, Kılınçel O, Muratdağı G, Aydın A, Usta MB. Factors affecting the anxiety levels of adolescents in home‐quarantine during COVID‐19 pandemic in Turkey. Asia Pac Psychiatry 2020;e12406.
2. World Health Organization Web Page (2021). Coronavirus Disease (COVID-19) Dashboard. [Access date: May 18, 2021. Available from: https://covid19.who.int/]
3. Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China. JAMA 2020;323(13):1239-42.
4. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 2020; 323(11):1061-69.
5. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. Lancet 2020; 395:1054-62.
6. Dai M, Liu D, Liu M, Zhou F, Li G, Chen Z, et al. Patients with cancer appear more vulnerable to SARS-CoV-2: A multicenter study during the COVID-19 outbreak. Cancer Discov 2020;10(6):783-91.
7. Chow N, Fleming-Dutra K, Gierke R, Hall A, Hughes M, Pilishvili T, et al. Preliminary estimates of the prevalence of selected underlying health conditions among patients with coronavirus disease 2019. MMWR Morb Mortal Wkly Rep 2020;69(13):382-86.
8. Wang Y, Di Y, Ye J, Wei W. Study on the public psychological states and its related factors during the outbreak of coronavirus disease 2019 (COVID-19) in some regions of China. Psychol Health Med 2021;26(1):13-22.
9. Pulvirenti F, Cinetto F, Milito C, Bonanni L, Pesce AM, Leodori G, et al. Health-related quality of life in common variable immunodeficiency Italian patients switched to remote assistance during the COVID-19 pandemic. J Allergy Clin Immunol Pract 2020;8:1894-9.
10. Global Initiative for Asthma 2020. Global Initiative for Asthma: Global strategy for asthma management and prevention (Updated 2020). Retrieved from: https://ginasthma.org/wp-content/uploads/2020/06/GINA-2020-report_20_06_04-1-wms.pdf.
11. Ehrenreich-May. (2020). Fear of Illness and Virus Evaluation (FIVE) – Adult Report Form. Retrieved from: https://adaa.org/sites/default/files/UofMiamiFear%20of%20Illness%20and%20Virus%20Evaluation%20(FIVE)%20scales%20for%20Child-%2C%20Parent%20and%20Adult-Report.pdf.
12. Çelikbaş Z. Validity and Reliability of The Turkish Version of The Fear of ilness and Virus Evaluatıon-Adult Report Form . Turkish Association for Psychopharmacology International Update Symposium, 10th-11th April 2021, Online Symposium, Oral Presentation, Abstract Book p. 75-78. Retrieved from:http://online.psychopharmacology-update2021.org/hibrit/kitap.pdf
13. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67(6):361-70.
14. Aydemir O, Guvenir T, Kuey L, Kultur S. Hospital anxiety and depression scale Turkish form; Validation and reliability study. Turk Psikiyatri Derg 1997;8(4): 280-87.
15. Tangye SG, Al-Herz W, Bousfiha A, Chatila T, Cunningham-Rundles C, Etzioni A, et al. Human inborn errors of immunity: 2019 update on the classification from the International Union of Immunological Societies Expert Committee. J Clin Immunol 2020; 40(1):24-64.
16. Bonilla FA, Khan DA, Ballas ZK, Chinen J, Frank MM, Hsu JT, et al. Practice parameter for the diagnosis and management of primary immunodeficiency. J Allergy Clin Immunol 2015; 136:1186-205.
17. Piazza-Waggoner C, Adams CD, Cottrell L, Taylor BK, Wilson NW, Hogan MB. Child and caregiver psychosocial functioning in pediatric immunodeficiency disorders. Ann Allergy Asthma Immunol 2006; 96:298-303.
18. Baloh C, Reddy A, Henson M, Prince K, Buckley R, Lugar P. 30-year review of pediatric- and adult-onset CVID: Clinical correlates and prognostic indicators. J Clin Immunol 2019; 39:678-87.
19. Heath JL, Saunders EFH, Lehman E, Craig TJ. Anxiety and depression in adults with primary immunodeficiencies: How much do these patients experience and what factors may increase patients’ risk? J Allergy Clin Immunol 2016;137:AB256.
20. Rosenberg SL, Miller GE, Brehm JM, Celedón JC. Stress and asthma: Novel insights on genetic, epigenetic, and immunologic mechanisms. J Allergy Clin Immunol 2014; 134:1009-15.
21. Çelebioğlu E. Asthma and COVID-19. Asthma Allergy Immunol 2020;18:56-7.
22. Lupia T, Scabini S, Mornese Pinna S, Di Perri G, De Rosa FG, Corcione S. 2019 Novel coronavirus (2019-nCoV) outbreak: A new challenge. J Glob Antimicrob Resist 2020;21:22-7.
23. Garg S, Kim L, Whitaker M, O’Halloran A, Cummings C, Holstein R, et al. Hospitalization rates and characteristics of patients hospitalized with laboratory-confirmed coronavirus disease-2019—COVID-NET, 14 States, March 1–30, 2020. MMWR Morb Mortal Wkly Rep 2020;69(15):458-64.
24. Akenroye AT, Wood R, Keet C. Asthma, biologics, corticosteroids, and coronavirus disease-2019. Ann Allergy Asthma Immunol 2020;125(1):12-3.
25. Çakmak ME, Kaya SB, Bostan ÖC, Tuncay G, Damadoğlu E, Karakaya G, et al. Mortality due to COVID-19 in a patient with severe asthma receiving omalizumab treatment: A case report. Asthma Allergy Immunol 2020;18( Supplement 1):27-9.
26. Çitak N, Pekçolaklar A. (2021). COVID-19 screening program should be performed in healthcare workers. Turk Thorac J 2021; 22(2):169-74.
27. Wong TW, Yau JKY, Chan CLW, Kwong RSY, Ho SMY, Lau CC, et al. The psychological impact of severe acute respiratory syndrome outbreak on healthcare workers in emergency departments and how they cope. Eur J Emerg Med. 2005;12:13-8.
28. Blake H, Bermingham F, Johnson G, Tabner A. Mitigating the psychological impact of COVID-19 on healthcare workers: A digital learning package. Int J Environ Res Public Health 2020; 17:2997.
29. Ayanian JZ. Mental health needs of health care workers providing frontline COVID-19 care. JAMA Health Forum 2020; e200397-e.
30. Elbay RY, Kurtulmuş A, Arpacıoğlu S, Karadere E. Depression, anxiety, stress levels of physicians and associated factors in COVID-19 pandemic. Psychiatry Res 2020; 113130.
31. Suppli NP, Johansen C, Christensen J, Kessing LV, Kroman N, Dalton SO. Increased risk for depression after breast cancer: A nationwide population-based cohort study of associated factors in Denmark, 1998-2011. J Clin Oncol 2014; 32:3831-9.
32. Brown LF, Kroenke K, Theobald DE, Wu J, Tu W. The association of depression and anxiety with health-related quality of life in cancer patients with depression and/or pain. Psycho-Oncology 2010; 19:734-41.
33. Raymond E, Thieblemont C, Alran S, Faivre S. Impact of the COVID-19 outbreak on the management of patients with cancer. Target Oncol 2020;15:249-59.
34. Zhang Y, Cui Y, Shen M, Zhang J, Liu B, Dai M, et al. Association of diabetes mellitus with disease severity and prognosis in COVID-19: A retrospective cohort study. Diabetes Res Clin Pract 2020;165:108227.
35. Zheng YY, Ma YT, Zhang JY, Xie X. COVID-19 and the cardiovascular system. Nat Rev Cardiol 2020;17:259-60.
36. Hu J , Zhang X , Zhang X, Zhao H, Lian J, Hao S, et al. COVID-19 patients with hypertension have a more severe condition, and ACEI/ARB treatment have no influence on the clinical severity and outcome. J Infect 2020;9:29.
37. Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020;579:270-3.
38. Cariou B, Hadjadj S, Wargny M, Pichelin M, Al-Salameh A, Allix I, et al. Phenotypic characteristics and prognosis of patients with COVID-19 and diabetes: the CORONADO study. Diabetologia 2020;63:1500-15.

APA	ÇÖLKESEN F, Kılınçel O, sözen m, YILDIZ E, BEYAZ Ş, Çölkesen F, Aytekin G, kocak m, ALSANCAK Y, araz m, Arslan S (2021). The Impact of SARS-CoV-2 Transmission Fear and the COVID-19 Pandemic on the Mental Health of Patients with Primary Immunodeficiency Disorders and Severe Asthma, and Other High-Risk Groups. , 84 - 91. 10.21911/aai.651
Chicago	ÇÖLKESEN FATİH,Kılınçel Oğuzhan,sözen mehmet,YILDIZ ERAY,BEYAZ Şengül,Çölkesen Fatma,Aytekin Gökhan,kocak mehmet zahid,ALSANCAK Yakup,araz murat,Arslan Sevket The Impact of SARS-CoV-2 Transmission Fear and the COVID-19 Pandemic on the Mental Health of Patients with Primary Immunodeficiency Disorders and Severe Asthma, and Other High-Risk Groups. (2021): 84 - 91. 10.21911/aai.651
MLA	ÇÖLKESEN FATİH,Kılınçel Oğuzhan,sözen mehmet,YILDIZ ERAY,BEYAZ Şengül,Çölkesen Fatma,Aytekin Gökhan,kocak mehmet zahid,ALSANCAK Yakup,araz murat,Arslan Sevket The Impact of SARS-CoV-2 Transmission Fear and the COVID-19 Pandemic on the Mental Health of Patients with Primary Immunodeficiency Disorders and Severe Asthma, and Other High-Risk Groups. , 2021, ss.84 - 91. 10.21911/aai.651
AMA	ÇÖLKESEN F,Kılınçel O,sözen m,YILDIZ E,BEYAZ Ş,Çölkesen F,Aytekin G,kocak m,ALSANCAK Y,araz m,Arslan S The Impact of SARS-CoV-2 Transmission Fear and the COVID-19 Pandemic on the Mental Health of Patients with Primary Immunodeficiency Disorders and Severe Asthma, and Other High-Risk Groups. . 2021; 84 - 91. 10.21911/aai.651
Vancouver	ÇÖLKESEN F,Kılınçel O,sözen m,YILDIZ E,BEYAZ Ş,Çölkesen F,Aytekin G,kocak m,ALSANCAK Y,araz m,Arslan S The Impact of SARS-CoV-2 Transmission Fear and the COVID-19 Pandemic on the Mental Health of Patients with Primary Immunodeficiency Disorders and Severe Asthma, and Other High-Risk Groups. . 2021; 84 - 91. 10.21911/aai.651
IEEE	ÇÖLKESEN F,Kılınçel O,sözen m,YILDIZ E,BEYAZ Ş,Çölkesen F,Aytekin G,kocak m,ALSANCAK Y,araz m,Arslan S "The Impact of SARS-CoV-2 Transmission Fear and the COVID-19 Pandemic on the Mental Health of Patients with Primary Immunodeficiency Disorders and Severe Asthma, and Other High-Risk Groups." , ss.84 - 91, 2021. 10.21911/aai.651
ISNAD	ÇÖLKESEN, FATİH vd. "The Impact of SARS-CoV-2 Transmission Fear and the COVID-19 Pandemic on the Mental Health of Patients with Primary Immunodeficiency Disorders and Severe Asthma, and Other High-Risk Groups". (2021), 84-91. https://doi.org/10.21911/aai.651

APA	ÇÖLKESEN F, Kılınçel O, sözen m, YILDIZ E, BEYAZ Ş, Çölkesen F, Aytekin G, kocak m, ALSANCAK Y, araz m, Arslan S (2021). The Impact of SARS-CoV-2 Transmission Fear and the COVID-19 Pandemic on the Mental Health of Patients with Primary Immunodeficiency Disorders and Severe Asthma, and Other High-Risk Groups. Astım Allerji İmmünoloji, 19(2), 84 - 91. 10.21911/aai.651
Chicago	ÇÖLKESEN FATİH,Kılınçel Oğuzhan,sözen mehmet,YILDIZ ERAY,BEYAZ Şengül,Çölkesen Fatma,Aytekin Gökhan,kocak mehmet zahid,ALSANCAK Yakup,araz murat,Arslan Sevket The Impact of SARS-CoV-2 Transmission Fear and the COVID-19 Pandemic on the Mental Health of Patients with Primary Immunodeficiency Disorders and Severe Asthma, and Other High-Risk Groups. Astım Allerji İmmünoloji 19, no.2 (2021): 84 - 91. 10.21911/aai.651
MLA	ÇÖLKESEN FATİH,Kılınçel Oğuzhan,sözen mehmet,YILDIZ ERAY,BEYAZ Şengül,Çölkesen Fatma,Aytekin Gökhan,kocak mehmet zahid,ALSANCAK Yakup,araz murat,Arslan Sevket The Impact of SARS-CoV-2 Transmission Fear and the COVID-19 Pandemic on the Mental Health of Patients with Primary Immunodeficiency Disorders and Severe Asthma, and Other High-Risk Groups. Astım Allerji İmmünoloji, vol.19, no.2, 2021, ss.84 - 91. 10.21911/aai.651
AMA	ÇÖLKESEN F,Kılınçel O,sözen m,YILDIZ E,BEYAZ Ş,Çölkesen F,Aytekin G,kocak m,ALSANCAK Y,araz m,Arslan S The Impact of SARS-CoV-2 Transmission Fear and the COVID-19 Pandemic on the Mental Health of Patients with Primary Immunodeficiency Disorders and Severe Asthma, and Other High-Risk Groups. Astım Allerji İmmünoloji. 2021; 19(2): 84 - 91. 10.21911/aai.651
Vancouver	ÇÖLKESEN F,Kılınçel O,sözen m,YILDIZ E,BEYAZ Ş,Çölkesen F,Aytekin G,kocak m,ALSANCAK Y,araz m,Arslan S The Impact of SARS-CoV-2 Transmission Fear and the COVID-19 Pandemic on the Mental Health of Patients with Primary Immunodeficiency Disorders and Severe Asthma, and Other High-Risk Groups. Astım Allerji İmmünoloji. 2021; 19(2): 84 - 91. 10.21911/aai.651
IEEE	ÇÖLKESEN F,Kılınçel O,sözen m,YILDIZ E,BEYAZ Ş,Çölkesen F,Aytekin G,kocak m,ALSANCAK Y,araz m,Arslan S "The Impact of SARS-CoV-2 Transmission Fear and the COVID-19 Pandemic on the Mental Health of Patients with Primary Immunodeficiency Disorders and Severe Asthma, and Other High-Risk Groups." Astım Allerji İmmünoloji, 19, ss.84 - 91, 2021. 10.21911/aai.651
ISNAD	ÇÖLKESEN, FATİH vd. "The Impact of SARS-CoV-2 Transmission Fear and the COVID-19 Pandemic on the Mental Health of Patients with Primary Immunodeficiency Disorders and Severe Asthma, and Other High-Risk Groups". Astım Allerji İmmünoloji 19/2 (2021), 84-91. https://doi.org/10.21911/aai.651